Trial intelligence / Profile preview

Basal insulin pump rate change study in adults with type 1 diabetes

ACTRN12612000449831Phase 4Completed

Sponsor
St Vincent's Hospital Melbourne
Start
Apr 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of insulin aspart in diabetes mellitus type 1 (T1D), sponsored by St Vincent's Hospital Melbourne. Primary endpoint: Time to reach steady state circulating insulin levels following a change in basal insulin infusion rate. Started Apr 2012; status: completed.

02

Drugs

insulin aspart
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on ACTRN12612000449831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612000449831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call